Description
NIVOLUNIX (NIVOLUMAB) 40MG INJECTION 1`S
Nivolumab injection is used alone or in combination with ipilimumab (Yervoy) to treat various types of cancers, including:
- Melanoma: For adults and children 12 years or older, either metastatic (spread to other parts of the body) or unresectable (cannot be removed by surgery). It is also used alone to prevent melanoma from returning after surgery.
- Lung Cancer: Used alone or in combination with ipilimumab and/or other chemotherapy medications to treat non-small cell lung cancer (NSCLC).
- Renal Cell Cancer: For kidney cancer.
- Hodgkin’s Lymphoma: Also known as Hodgkin’s disease.
- Head and Neck Cancer
- Urothelial Cancer: Affects the lining of the bladder and urinary tract.
- Colorectal Cancer: Begins in the large intestine.
- Hepatocellular Carcinoma (HCC): A type of liver cancer.
- Esophageal Cancer: Cancer of the tube connecting the throat to the stomach.
- Gastric Cancer: Cancer of the stomach.
- Gastroesophageal Junction Cancer: Located where the stomach meets the esophagus.
- Malignant Pleural Mesothelioma: Affects the lining of the lungs and chest cavity.
Nivolumab belongs to a class of medications called monoclonal antibodies. It works by helping the immune system slow or stop the growth of cancer cells.
Usage
Nivolumab is administered as an intravenous (IV) infusion over 30 minutes by a healthcare professional in a medical facility. The frequency of administration depends on whether it is used alone or in combination with other medications:
- Alone: Usually given once every 2 or 4 weeks.
- In Combination: Typically administered once every 2, 3, or 4 weeks, depending on the treatment plan.
Your doctor will determine the appropriate schedule based on your condition and response to the medication.
Precautions During Infusion
NIVOLUNIX (NIVOLUMAB) 40MG INJECTION 1`S can cause serious or life-threatening reactions during the infusion. A healthcare professional will monitor you closely during and after the infusion for symptoms such as chills, shaking, itching, rash, flushing, difficulty breathing, dizziness, fever, and feeling faint. Inform your doctor or nurse immediately if you experience any of these symptoms.
Depending on your response and any side effects, your doctor may adjust your infusion rate, delay treatment, or stop it altogether. Additional medications may be provided to manage side effects.
